Nibec KRX:138610KOSDAQ
나이벡 · Korean news coverage and regulatory filings, organized.
In Q3 2026, Nibec reported revenue of ₩4.5bn, down 13.0% year on year, and an operating loss of ₩783m. Nibec (나이벡) appeared in 3 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Nov 9 with 4 articles. The most common catalyst was contracts & orders (2). It was most often mentioned alongside 글로벌테크놀로지, Jeil Pharmaceutical and LigaChem Biosciences.
Nibec today: up or down?
No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.
Upcoming dates as filed
- Mar 31 Annual report filing deadlinein 135 days · period ending Dec 2026
Dates Nibec stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.
Nibec quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q3 2026 | ₩4.5bn | -13.0% | −₩783m margin −17.4% | −₩3.2bn |
| Q2 2026 | ₩6.1bn | -61.6% | ₩103m margin 1.7% | ₩381m |
| Q1 2026 | ₩5.2bn | -6.7% | ₩137m margin 2.6% | ₩1.1bn |
| Q4 2025 derived | ₩6.1bn | -3.8% | −₩1.2bn margin −18.8% | −₩1.1bn |
| Q3 2025 | ₩5.2bn | -10.7% | −₩993m margin −19.2% | −₩454m |
| Q2 2025 | ₩15.8bn | +165.0% | ₩8.4bn margin 53.1% | ₩7.7bn |
| Q1 2025 | ₩5.6bn | -12.6% | −₩1.2bn margin −21.8% | −₩1.5bn |
| Q4 2024 derived | ₩6.4bn | +37.4% | −₩5.8bn margin −90.8% | −₩2.6bn |
Nibec ranks #1708 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Nibec top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Nibec news Korean headlines
-
NaiVec pursues new drug commercialization for obesity and cardiometabolic disease at BioEurope
1 more on this story · 1 outlets
-
Naybec confirms regeneration possibility of collagen material Regenomer to tooth support tissues
3 more on this story · 2 outlets
- Naivek confirms possibility of tooth support tissue regeneration in beagle dogs메디포뉴스 · Oct 21 10:25
- Naibec confirms regeneration potential of gum bone and tooth support tissues이데일리 · Oct 21 11:50
- Naibec confirms regeneration potential of gum bone and tooth support tissues이데일리 · Oct 21 11:51
-
Naivec to meet global companies including Straumann at EAO 2026, strengthening European market push
1 more on this story · 1 outlets
-
Naivec to expand regenerative biomaterial global business at EAO 2026
1 more on this story · 1 outlets